Editorial: COVID-19 and thrombo-inflammatory responses

Frontiers in Cardiovascular Medicine

Cardiovascular Medicine

Christoph Reinhardt¹  Paresh P. Kulkarni²  Saravanan Subramaniam³  Luca Spiezia⁴ 

[1] Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany;German Center for Cardiovascular Research (DZHK), Partner Site RhineMain, Mainz, Germany;Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India;Pulmonary Center, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, United States;Thrombosis and Hemorrhagic Diseases Unit Medicine, Padova University Hospital, Padova, Italy;

关键词: COVID-19;    thrombo-inflammation;    long covid;    VITT;    platelets and COVID-19;    thrombocytopenia;    thromboprophylaxis regimens;   

DOI  :  10.3389/fcvm.2023.1231909

 received in 2023-05-31, accepted in 2023-06-06,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
© 2023 Subramaniam, Reinhardt, Kulkarni and Spiezia.